Skip to main content

Accelerate your path to market

Integrated OEM Solutions

A fully integrated partner that brings development, regulatory, and manufacturing together under one accountable model, removing the complexity of managing multiple vendors.

Why Integrated OEM Solutions

Accelerating Launches through Partnership

Changing how programs move forward, from innovation to readiness

Speed-to-Launch

Parallel development, regulatory, and manufacturing workflows help move programs to launch in as little as 6 to 12 months

Accelerated TimelinesParallel Execution

Built-in Accountability

A single, integrated model ensures clear ownership and aligned decision-making across every stage of the program.

Clear ownershipPredictability

No handoffs, no gaps

Development, regulatory, and manufacturing operate as one continuous system, reducing friction, rework, and misalignment between teams.

ContinuityIntegrated model

Regulatory-Ready

Programs are structured with regulatory strategy, documentation, and validation built in from the start, not added later.

Market clearance

Designed as a system

Implants, instruments, and trays are developed together as one system to improve clinical flow, supporting both surgeon performance and patient care.

Procedural alignment

Faster path to commercialization

A connected model shortens the transition from development to market entry, enabling earlier adoption and helping unlock revenue sooner.

Early market entry

What’s included

  • Regulatory strategy and submission planning aligned to intended use, claims, and jurisdiction
  • Technical documentation support, including risk management, verification and validation planning, and evidence mapping
  • Guidance for platform-based configurations, extensions, and new indications
  • QMS alignment to support audit readiness and global approvals
What’s included

Regulatory and Quality

Regulatory strategy built into development

Regulatory planning is built in from day one.

Development is aligned with 510(k) and EU MDR expectations from the start, with documentation, testing, and validation strategy built into the model.

Regulatory strategy built into development

How It Works

A connected, end-to-end approach

Bringing development, regulatory, and manufacturing together for turnkey systems, with precision production at scale and on schedule.

Create

Whiteboard to concept

Clinical inputs, VOC, feasibility

Design

Engineering and platforms

Technology bricks, platforms, IP

Build

DFM and production

Process dev, tooling, validation

Clear

Regulatory strategy

510(k), CE-MDR, technical files

Launch

Market entry

Commercialization, market access

Scale

Growth and supply

Volume production, post-market

Integrated OEM Solutions

Turnkey systems

Concept to Launch

The Integrated Model

From Concept to Launch, Without the Gaps

Design, regulatory, manufacturing, and validation aligned from day one.

INPUTS
EXALTA CORE
END MARKETS
  1. Inputs

    • Industrial + Mechanical Design

      Early design inputs help shape device requirements, usability, manufacturability, and the path to launch.

    • Clinical Insights

      Surgeon and KOL input help align implants, instruments, and trays with how products are used in the OR.

    • Testing

      Testing inputs help validate design choices, reduce late-stage surprises, and support regulatory readiness.

    • Precision Manufacturing

      Manufacturing input helps align design intent with process capability, scalability, and repeatable production across the EXALTA network

  2. EXALTA Core

    • System Development

      Implant, instrument, and tray systems developed together to support procedural use and launch readiness.

    • Program Management

      Single accountable program team drives schedule, cost, and risk from concept to launch.

    • Regulatory Strategy

      510(k), PMA, and EU MDR pathways planned in parallel along with development. Not after.

    • Verification & Validation

      Integrated V&V planning and execution help confirm product performance, usability, and readiness for submission or launch.

    • Sterilization

      Packaging & Sterilization strategy backed by microbiology support help prepare programs for validation, clearance, and market release.

  3. Regulatory Trust

    • ISO 13485

      Quality management systems aligned with medical device development, manufacturing, traceability, and compliance.

    • FDA 510(k)

      Regulatory support for U.S. market pathways, including testing strategy, documentation, and submission readiness.

    • EU MDR

      European Medical Device Regulation expertise across technical files, clinical evaluation, and CE marking readiness.

    • ISO 17025 | Microbio Lab

      In-house accredited microbiology laboratory supporting bioburden, endotoxin, cleaning validation, and sterilization readiness.

  4. End Markets

    • Spine, Extremities & Trauma

      Fusion, fixation, and extremity platforms across core orthopedic applications.

    • Sports Medicine

      Instrument, implant, and procedure-specific solutions supporting arthroscopy, soft tissue repair, and sports medicine systems.

    • Cardiothoracic

      Sternal closure, thoracic fixation, and instrument systems built for precision and procedural reliability.

    • ENT (Ear, Nose & Throat)

      Burrs, blades, flexible shafts, and specialty instruments built for ENT and sinus procedures.

    • Enabling Technologies

      Navigation-ready instruments, robotic components, and smart systems built for next-generation procedural platforms.

Inputs EXALTA Core Regulatory Trust End Markets

Ready to explore an integrated OEM partnership?

Whether you need a full product lifecycle partner or support for a specific development phase, our team is ready to discuss how EXALTA can accelerate your next product launch.